STOCK ALERT: BUY OTC BB : RJVN The Company profiled below is expected to announce several major accomplishments via Press Releases, which could dramatically effect its stock price over the next 30-days. You can be among the first to receive this information by opting-in to our mailing list at this time. You will receive live and timely updates regarding the company profiled below as well as free trials to valuable investment tools. See Opt-in instructions below.
Buy OTC BB : RJVN - Investors who are still making money in the stock market are those who know what stocks are in play or stocks about to be promoted/syndicated. By now you probably realize that stocks don't just go up but are pushed up by brokerage firms that give companies exposure and analyst coverage, they promote them! To make money, an investor needs to buy at the beginning of the PUSH and sell within a 60-day period. We report on which stocks are being pushed and at what price levels to buy and sell at. Our current pick, OTC BB : RJVN is ready to move quickly with news to be released and a promotion underway. Company----------RJV Networks, Inc. Symbol-----------RJVN Current Price----$0.26 52 Week High-----$2.10 52 Week Low------$0.12 Target Price $2 in Q1/2003 Update: Experts agree that RJVN cancer treatment therapies capable of treating most cancers. Investment Highlights RJVN projects it will be able to treat most cancers with its combined targeted therapy treatment, which is based upon an astounding discovery by a molecular biologist at the Univ. of Michigan - The causal link to breast and most other malignancies and cancers in the protein Mammastatin. RJVN has developed a series of cancer treatment therapies, which utilize pan-cancer market antibodies. Antibody therapies do not create chemical toxicity and, as such, are fast tracked through the regulatory approval process. Using the therapy approach, RJVN is targeted to enter testing for its products this spring. RJVN's combination of two leading, well known technologies previously announced by BioCurex and InNexus Corp along with RJVN's key MAb protein replicating technology has allowed the Company to create a series of patented therapeutic products that many molecular biologists believe will treat most cancers. RJVN's R&D and Management are led by Dr. John Todd, Dr. Charles Morgan (a world renowned molecular biologist and 5 other industry leading Dr's all with several years experience in bio-tech development. For more info see RJVN in the news. ******************* Special Offer ******************* As a member of our opt-in mailing list, you will be among the first to receive up to the minute information regarding the company profiled above as well as a free 10-day trial to a website with real-time Level II quotes, research reports, OTC BB promo / syndication calendar, trading chat rooms, full threading message boards, along with many other valuable and free investment tools not readily available to the general public. This is an incredible opportunity! Just click the link below to send us an email, and you will be immediately added to our Opt-in list. Please be sure that "opt-in" is in the subject line of the email. MailTo:[EMAIL PROTECTED]?Subject=opt-in . Thank you. ***********************Disclaimer******************** Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects", "estimates," "believes," "understands" "will," "anticipates," or that by statements indicating certain actions "may," "could," or "might" occur. All information provided within this email pertaining to investing, stocks, securities must be understood as information provided and not investment advice. Emerging Equity Alert advises all readers and subscribers to seek advice from a registered professional securities representative before deciding to trade in stocks featured within this email. None of the material within this report shall be construed as any kind of investment advice. In compliance with the Securities Act of 1933, Section 17(b), Emerging Stock Alert discloses the receipt of 125,000 unrestricted shares of RJVN from a third party for the publication of this report. Be aware of an inherent conflict of interest resulting from such compensation due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. All factual information in this report was gathered from public sources, including but not limited to SEC filings, Company Press Releases, and Market Guide. Emerging Equity Alert believes this information to be reliable but can make no guarantee as to its accuracy or completeness. Use of the material within this email constitutes your acceptance of these terms. ****** Advertising Disclaimer ****** We are an internet advertising company and have received a monetary payment for this mailing service. We hold no stocks and have no personal interest in this company whatsoever. We are simply being paid to perform a service. This message is an advertisement. ****** Removal Instructions ****** This message has been sent to you in compliance with our strict anti-abuse regulations. We will continue to bring you valuable offers on the products and services that interest you most. If you do not wish to receive further mailings, please click below. We respect all removal requests. To be removed immediately from our mailing lists just click on the link below: MailTo:[EMAIL PROTECTED]?Subject=Remove-me . Be sure that "Remove-me" is in the subject line of the email prior to sending it. To Unsubscribe: send mail to [EMAIL PROTECTED] with "unsubscribe freebsd-hackers" in the body of the message
